Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Nucleotide variations of TP53 exon 4 found in intracranial meningioma and in silico prediction of their significance.

Bukovac A, Kafka A, Hrašćan R, Vladušić T, Pećina-Šlaus N.

Mol Clin Oncol. 2019 Dec;11(6):563-572. doi: 10.3892/mco.2019.1936. Epub 2019 Oct 15.

2.

Comparable Genomic Copy Number Aberrations Differ across Astrocytoma Malignancy Grades.

Pećina-Šlaus N, Kafka A, Gotovac Jerčić K, Logara M, Bukovac A, Bakarić R, Borovečki F.

Int J Mol Sci. 2019 Mar 12;20(5). pii: E1251. doi: 10.3390/ijms20051251.

3.

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Vogl UM, Andalibi H, Klaus A, Vormittag L, Schima W, Heinrich B, Kafka A, Winkler T, Öhler L.

BMC Cancer. 2019 Jan 8;19(1):28. doi: 10.1186/s12885-018-5240-6.

4.

Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.

Kafka A, Bačić M, Tomas D, Žarković K, Bukovac A, Njirić N, Mrak G, Krsnik Ž, Pećina-Šlaus N.

J Cell Mol Med. 2019 Jan;23(1):641-655. doi: 10.1111/jcmm.13969. Epub 2018 Nov 23.

5.

Hypermethylation of Secreted Frizzled Related Protein 1 gene promoter in different astrocytoma grades.

Kafka A, Karin-Kujundžić V, Šerman L, Bukovac A, Njirić N, Jakovčević A, Pećina-Šlaus N.

Croat Med J. 2018 Oct 31;59(5):213-223.

6.

Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma.

Kafka A, Tomas D, Lechpammer M, Gabud T, Pažanin L, Pećina-Šlaus N.

Dis Markers. 2017;2017:9253495. doi: 10.1155/2017/9253495. Epub 2017 Oct 19.

7.

Genetic changes of MLH1 and MSH2 genes could explain constant findings on microsatellite instability in intracranial meningioma.

Pećina-Šlaus N, Kafka A, Bukovac A, Vladušić T, Tomas D, Hrašćan R.

Tumour Biol. 2017 Jul;39(7):1010428317705791. doi: 10.1177/1010428317705791.

PMID:
28705114
8.

An Integrated Data-Driven Strategy for Safe-by-Design Nanoparticles: The FP7 MODERN Project.

Brehm M, Kafka A, Bamler M, Kühne R, Schüürmann G, Sikk L, Burk J, Burk P, Tamm T, Tämm K, Pokhrel S, Mädler L, Kahru A, Aruoja V, Sihtmäe M, Scott-Fordsmand J, Sorensen PB, Escorihuela L, Roca CP, Fernández A, Giralt F, Rallo R.

Adv Exp Med Biol. 2017;947:257-301. doi: 10.1007/978-3-319-47754-1_9. Review.

PMID:
28168671
9.

AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin.

Pećina-Šlaus N, Kafka A, Vladušić T, Pećina HI, Hrašćan R.

Anticancer Res. 2016 Sep;36(9):4583-94.

PMID:
27630299
10.

Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling.

Pećina-Šlaus N, Kafka A, Lechpammer M.

Cancers (Basel). 2016 Jul 15;8(7). pii: E67. doi: 10.3390/cancers8070067. Review.

11.

Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Pećina-Šlaus N, Kafka A, Vladušić T, Tomas D, Logara M, Skoko J, Hrašćan R.

Int J Exp Pathol. 2016 Apr;97(2):159-69. doi: 10.1111/iep.12186. Epub 2016 Jun 12.

12.

Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.

Pećina-Šlaus N, Kafka A, Varošanec AM, Marković L, Krsnik Ž, Njirić N, Mrak G.

Mol Med Rep. 2016 May;13(5):4245-51. doi: 10.3892/mmr.2016.5061. Epub 2016 Mar 28.

13.

Wnt signaling and astrocytic brain tumors.

Pećina-Šlaus N, Kafka A.

CNS Oncol. 2015;4(6):369-70. No abstract available.

14.

Genetic changes observed in a case of adult pilocytic astrocytoma revealed by array CGH analysis.

Pećina-Šlaus N, Gotovac K, Kafka A, Tomas D, Borovečki F.

Mol Cytogenet. 2014 Dec 23;7(1):95. doi: 10.1186/s13039-014-0095-2. eCollection 2014.

15.

The cellular story of dishevelleds.

Kafka A, Bašić-Kinda S, Pećina-Šlaus N.

Croat Med J. 2014 Oct;55(5):459-67. Review.

16.

Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin.

Kafka A, Tomas D, Beroš V, Pećina HI, Zeljko M, Pećina-Šlaus N.

Int J Mol Sci. 2014 Jun 13;15(6):10635-51. doi: 10.3390/ijms150610635.

17.

Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors.

Pećina-Šlaus N, Kafka A, Tomas D, Marković L, Okštajner PK, Sukser V, Krušlin B.

Histol Histopathol. 2014 Dec;29(12):1557-64. doi: 10.14670/HH-29.1557. Epub 2014 May 23.

PMID:
24858819
18.

Epithelial-to-mesenchymal transition: possible role in meningiomas.

Pecina-Slaus N, Cicvara-Pecina T, Kafka A.

Front Biosci (Elite Ed). 2012 Jan 1;4:889-96. Review.

PMID:
22201922
19.

The application of MALDI TOF MS in biopharmaceutical research.

Kafka AP, Kleffmann T, Rades T, McDowell A.

Int J Pharm. 2011 Sep 30;417(1-2):70-82. doi: 10.1016/j.ijpharm.2010.12.010. Epub 2010 Dec 13. Review.

PMID:
21147205
20.

Release and bioactivity of PACA nanoparticles containing D-Lys⁶-GnRH for brushtail possum fertility control.

Kafka AP, McLeod BJ, Rades T, McDowell A.

J Control Release. 2011 Feb 10;149(3):307-13. doi: 10.1016/j.jconrel.2010.10.029. Epub 2010 Oct 31.

PMID:
21047541
21.

Characterization of Peptide Polymer Interactions in Poly(alkylcyanoacrylate) Nanoparticles: A Mass Spectrometric Approach.

Kafka AP, Kleffmann T, Rades T, McDowell A.

Curr Drug Deliv. 2010 Jul;7(3):208-15.

PMID:
20497104
22.

Characterization of Peptide Polymer Interactions in Poly(alkylcyanoacrylate) Nanoparticles: A Mass Spectrometric Approach.

Kafka AP, Kleffmann T, Rades T, McDowell A.

Curr Drug Deliv. 2010 Feb 17. [Epub ahead of print]

PMID:
20158486
23.

Histidine residues in the peptide D-Lys(6)-GnRH: potential for copolymerization in polymeric nanoparticles.

Kafka AP, Kleffmann T, Rades T, McDowell A.

Mol Pharm. 2009 Sep-Oct;6(5):1483-91. doi: 10.1021/mp900043e.

PMID:
19655810
25.

Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer.

Jäger C, Kafka A, Bossert S, Grundmann R, Windisch J, Kreienberg R, Heilmann V.

Anticancer Res. 2004 Sep-Oct;24(5B):3209-14.

26.
27.

Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing.

Luftner D, Henschke P, Kafka A, Anagnostopoulos I, Wiechen K, Geppert R, Stein H, Wernecke KD, Kreienberg R, Possinger K.

Int J Biol Markers. 2004 Jan-Mar;19(1):1-13.

PMID:
15077921
28.

[From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma].

Kreienberg R, Kafka A.

MMW Fortschr Med. 2003 Jun 12;145(24):32-3. German. No abstract available.

PMID:
12866296
29.

Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.

Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H.

Int J Oncol. 2003 May;22(5):1117-21.

PMID:
12684679
30.

[Modern therapy of breast carcinoma: more time for living].

Kreienberg R, Kafka A.

Pflege Z. 2003 Jan;56(1):11-4. German. No abstract available.

PMID:
12630203
31.
32.

[New records in vaccinations].

KAFKA A, KREJCI F.

Cesk Zdrav. 1956 Mar;4(3):168-73. Czech. No abstract available.

PMID:
13316977

Supplemental Content

Support Center